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FACTORS INFLUENCING THE RECEIPT OF DIABETIC RETINOPATHY 
SCREENING IN A HIGH-RISK POPULATION.  
 
Elizabeth Fairless, Amber King, Kristen H. Nwanyanwu. Department of Ophthalmology 
& Visual Science, Yale School of Medicine, New Haven, CT.  
 
 
Diabetic retinopathy (DR) is among the leading causes of vision loss in the US, 
yet an estimated 50% of patients with diabetes do not receive recommended annual 
screening eye exams for reasons that are incompletely understood. Patients with diabetes 
and low socioeconomic status or who are racial/ethnic minorities are at increased risk for 
vision loss. Qualitative interviews were conducted with 30 patients with diabetes at a 
federally qualified community health center and a primary care clinic in New Haven, CT 
regarding factors influencing their use of screening exams. The interviews were recorded, 
transcribed, and analyzed line by line to identify themes. The themes were organized in a 
theoretical framework of factors influencing receipt of screening. Participants identified 
as black (16), white (5), Hispanic (5), Asian (1), and other/no answer (3). Twenty-eight 
had health insurance. Twenty-four had received an eye exam within in the past year, but 
one-third of participants reported they did not receive eye exam yearly. 415 comments 
were coded at 22 nodes under 7 broader themes and two overarching categories of 
individual factors and institutional/structural factors. Themes included vision status, 
competing concerns, emotional context, resource availability, in-clinic experience, cues 
to action, and knowledge about diabetes. Among the patients who had not received an 
eye exam within the past year, the cost of an exam, lack of insurance coverage, and lack 
of prompting by a health provider were among the reported reasons for not pursuing eye 
screenings. Many patients lack knowledge about diabetic retinopathy and the utility of 
preventative eye care. New strategies for engaging high-risk populations are necessary.  
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I. The Diabetes Epidemic  
The number of people with diabetes mellitus in the United States and worldwide 
is rapidly expanding, leading some scholars to call diabetes the largest epidemic in 
human history [1]. Past predictions have underestimated the number of people worldwide 
who would develop diabetes. In 2000, the World Health Organization (WHO) predicted 
there would be 366 million people worldwide with diabetes by 2030, but by 2015 there 
were already 415 million people with the disease [1]. In the United States in 2015, there 
were an estimated 30 million people with diabetes, equaling 9.4% of the population [2]. 
The WHO estimates that 1.6 million deaths in 2016 worldwide were directly attributable 
to diabetes [3].  
 
Diabetes mellitus is a chronic metabolic disease characterized by elevated blood 
glucose that over time causes macrovascular and microvascular damage throughout the 
body. Diabetes can lead to serious morbidity including cardiovascular disease, stroke, 
kidney disease, and limb amputations. Type 2 diabetes, characterized by insulin 
resistance, is the most common type. Type 1 diabetes, also known as juvenile diabetes, is 
characterized by impaired insulin production. The risk factors for type 2 diabetes are 
heterogenous. Obesity, inactivity, and poor diet have demonstrable links to an increased 
risk of diabetes, and correspondingly, lifestyle interventions aimed at addressing these 
factors have been shown to reduce the incidence of diabetes [3,4].  However, other non-
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modifiable factors such as genetic susceptibility and epigenetic changes are increasingly 
being recognized [1,4,5].  
 
There are disparities in who is affected by diabetes. According to the Centers for 
Disease Control, in the United States in 2015 the prevalence of diabetes was 12.7% for 
non-Hispanic blacks, 12.1% for Hispanics, 8% for Asians, and 7.4% for whites [2]. 
American Indians/Alaska Natives had over double the prevalence (15.1%) compared to 
whites. Indigenous people are disproportionally affected by diabetes, with some 
Aboriginal Australian communities and Native American communities having the highest 
rates of diabetes in the world [1]. Black, Hispanic, and Native American people are also 
more likely than their white counterparts to suffer complications from diabetes, such as 
diabetic retinopathy [6]. 
 
II. Diabetic Retinopathy 
Diabetic retinopathy (DR) is a microvascular and neurodegenerative complication 
of diabetes. Chronic hyperglycemia triggers a cascade of biochemical changes within the 
retina that include increased inflammation, oxidative stress, and advanced glycation end-
products that result in vascular damage and neuroretinal compromise [7]. The initial 
disease stages are a spectrum of non-proliferative retinopathy characterized by vascular 
endothelial injury within the blood vessels of the retina. This vascular damage leads to 
microhemorrhages, microaneurysms, retinal infracts, or leakage of lipids and plasma 
proteins into the retina [5]. If this leakage occurs in the macula, it can cause macular 
edema and vision loss. Over time, retinal non-perfusion can trigger growth of abnormal 
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retinal blood vessels, a state termed proliferative diabetic retinopathy. This 
neovascularization can extend into the vitreous, putting traction on the retina and leading 
to detachment. In addition, the fragile, abnormal vessels easily hemorrhage. Both of these 
complications can lead to severe vision loss [5,8].  The presence of DR heralds systemic 
vascular complications: it is associated with double to triple the risk of stroke, coronary 
artery disease, and heart failure [9–11].  
 
One meta-analysis estimates that there are 93 million people worldwide with DR, 
including 28 million with vision-threatening DR [12]. In the United States, diabetic 
retinopathy is among the leading causes of vision impairment and blindness [5]. The 
prevalence of DR in patients with diabetes is approximately 30% [13]. DR can occur in 
both type 1 and type 2 diabetes. Nearly all patients with type 1 diabetes eventually 
develop retinopathy and 50-60% of patients with type 2 diabetes develop some degree of 
retinopathy during their lifetime [8,13]. Up to 21% of patients with type 2 diabetes 
already have retinopathy at the time of their first diagnosis with diabetes [8]. One in ten 
people with diabetes will develop a vision-threatening form of DR [14].  
 
There are a number of risk factors for DR that are well-documented, including 
poor glycemic control, poor blood pressure control, and a longer duration of diabetes 
[12]. However, these factors only account for some of the risk of developing DR, and 
much of the remaining risk is not well understood [15]. Socioeconomic factors may have 
a profound effect the health of patients with diabetes and their ability to influence the 
aforementioned risk factors [16]. Socioeconomic status can potentially affect many facets 
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of a patient’s experience, from access to medical care, community resources, and social 
support, to knowledge about diabetes, communication with providers, and ability to 
adhere to treatment plans [16].  The environment in which a patient lives may influence 
their risk for diabetes and its complications. For example, whether a patient lives in a 
neighborhood that is safe, walkable, and with access to healthy foods [17].  
 
Paralleling the racial disparities in the prevalence of diabetes, racial and ethnic 
minorities are also at increased risk of developing DR and vision-threatening forms of 
DR [2,18–20]. In one study that examined the third National Health and Nutrition 
Examination Survey (NHANES III) data, non-Hispanic Blacks were found to have a 
prevalence of DR 46% higher than non-Hispanic Whites, and Mexican-Americans were 
found to have a prevalence of DR 84% higher [20].  For Native Americans, there are few 
studies of DR rates. Prevalence of DR in this population has been documented as 
between 38-59% in reports from the 1980s and 1990s, whereas a newer study places the 
prevalence of DR at 20% [21].  
 
 
III. Prevention and Treatment of Diabetic Retinopathy and the Role of Screening  
Blindness from diabetic retinopathy is largely preventable, yet one in ten people 
with diabetes will develop vision-threatening DR [14,22]. Diabetic retinopathy, like 
many eye diseases, has no early symptoms or warning signs [5]. Many patients with DR 
are unaware they have the condition: one study of NHANES data from 2005-2008 
found that of patients with DR evident on fundus photographs, only 26.1% answered 
yes to “Have you been told by a doctor that diabetes has affected your eyes or that you 
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had retinopathy?” [23]. Of patients with diabetic macular edema, only 44.7% answered 
yes [23].  
 
Intensive glycemic and blood pressure control can significantly reduce the risk 
of developing DR and slow its progression [24,25]. A 1% reduction in glycated 
hemoglobin (HbA1c) can reduce the risk of retinopathy by approximately 40% [5,7,24]. 
Tight blood pressure control (< 150/85 mm Hg) can reduce the risk of DR progression 
by approximately one-third [25]. Treatments to reduce vision loss in proliferative DR 
include panretinal laser photocoagulation or intravitreal anti-vascular endothelial 
growth factor (VEGF) therapy, each aimed at reducing the pro-angiogenic signaling that 
leads to neovascularization in the retina [5]. Anti-VEGF therapies can also be used to 
treat diabetic macular edema, as can intraocular steroids in some cases [5]. In patients 
with a tractional retinal detachment or persistent vitreous hemorrhage, surgical removal 
of the vitreous (vitrectomy) may be necessary [7]. These treatments for DR are highly 
effective and can reduce severe vision loss by 50- 94% [26,27].  
 
Early detection of DR through routine eye examinations and early treatment is 
key to prevent major vision loss [5,28]. The rationale for screening for DR is clear: DR 
is highly prevalent within a distinct group of people (patients with diabetes), early 
disease is asymptomatic and can be easily detected with screening methods, and there 
are effective treatments that can reduce disease burden [5]. Screening is also a cost-
effective intervention, saving approximately $100 million federal dollars annually 
[26,29]. 
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Screening guidelines recommend that patients with type 2 diabetes be screened 
for DR with a comprehensive dilated eye examination at the time of their diagnosis and 
annually thereafter. Adult patients with type 1 diabetes should be screened annually after 
they’ve had the disease for greater than five years [8,30].  Although screening with a 
clinical examination by an ophthalmologist would be ideal, there are logistical and 
resource limitations to screening every patient with diabetes in this manner. The 
invention of non-mydriatic digital retinal photography offers a new solution large-scale 
DR screening. Retinal photographs can be taken in a primary care setting and transmitted 
to reading centers where they can be evaluated for DR, and appropriate referrals to an 
ophthalmologist can then be made [5].  
 
IV. Utilization of Screening for Diabetic Retinopathy 
Despite the importance of annual screening for DR in order to receive early 
treatment and prevent vision loss, it is estimated that non-adherence to screening is 
high. Various studies estimate that between 35-50% of patients with diabetes do not 
receive necessary screening [22,26,31,32]. There are a number of factors that have been 
shown to be associated with receipt of appropriate screening, or eye care utilization 
more generally. These include, but are not limited to, socioeconomic status, insurance 
status, access to care, and race/ethnicity.  
 
Socioeconomic status. Zhang et al. found that patients with any age-related eye 
disease (age-related macular degeneration, cataract, diabetic retinopathy, or glaucoma) 
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were less likely to have had an eye examination in the last year if they had a lower 
income or less than a high school education [33]. Chou et al. found similar disparities 
along income and educational lines using data from the 2006-2009 Behavioral Risk 
Factor Surveillance System [34].  
 
Insurance status. A study by Lee et al. used data from the National Health 
Interview Survey to examine eye care utilization. For people without insurance, eye 
care utilization rates of 14%, 24%, and 36% were found for people with no, some, or 
severe visual impairment respectively. For those with insurance, utilization rates were 
found to be significantly higher at 34%, 54%, and 60% for the same degrees of visual 
impairment, respectively [35]. A study by Shi et al. using data from the Medical 
Expenditure Panel Survey Household Component (2002–2009) including the Diabetes 
Care Survey found that insurance was the most significant factor for receiving an eye 
examination, but noted racial/ethnic disparities even among insured patients [36] 
 
Access to care. People living in rural areas have been shown to have lower rates 
of eye care utilization [37]. Native Americans have well documented barriers to access 
and utilization of healthcare, even if they reside in urban areas [38]. 
 
Race/ethnicity. Racial/ethnic minority status has consistently been shown to be 
associated with decreased utilization of eye examinations and decreased access to eye 
care [26,36,39–41]. Lee et al found lower rates of eye care utilization among certain 
Hispanic subgroups: Mexican Americans and Cuban Americans [35]. In the SEE 
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Project, a population-based survey of persons aged 65-84 in Maryland, only half of 
black participants reported seeing an eye doctor in the past year, compared to 69% for 
white participants [42]. In one study at a large Indian Health Service clinic, adherence 
to DR screening was 50%, although this was able to be increased to 75% with 
implementation of a digital retinal imaging system in the primary care setting [43].  
 
V. Purpose of Current Study  
A review of the literature has demonstrated that the patient populations with 
greater disease burden from diabetic retinopathy, in particular racial/ethnic minorities and 
those with low socioeconomic status, are also the same patient populations less likely to 
get necessary screening examinations. In other words, the patients that need screening the 
most are less likely to receive it. As detailed above, there are a complex network of 
biologic, socioeconomic, and environmental factors that influence the risk of developing 
diabetes and diabetes-related complications, and influence screening utilization. 
Understanding and intervening upon these factors is key to improving outcomes for 
patients with diabetes.  
 
Despite a wealth of data indicating disparities in DR screening utilization, there 
remains relatively few studies that examine patient perspectives on screening, especially 
from patient populations at high risk for vision loss, namely racial/ethnic minorities and 
those with low socioeconomic status. Previous studies have used focus groups to 
investigate the receipt of eye care more generally and have shown that patients’ perceived 
barriers to eye care include cost, insurance status, transportation, lack of communication 
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with the physician, lack of trust, burden of systemic disease, absence of symptoms, and 
no perceived need for examination [20,28,44,45]. Elam and Lee conducted focus groups 
with high risk patients in North Carolina and found that a lack of trust in their provider or 
in the healthcare system was the most common barrier cited among under-utilizers of eye 
care [44]. Alexander et al. conducted focus groups with randomly selected participants 
from each racial group and reported participants generally lacked knowledge about eye 
health and that few were counseled by their primary care providers about eye care [28]. 
Fisher et al. conducted focus groups about adherence to dilated eye exams with both 
patients with diabetes and with physicians in internal medicine and ophthalmology.  The 
authors report that a lack of awareness of insurance benefits was the most common 
barrier identified by patients, whereas a lack of education about the importance of eye 
exams was the most common barrier reported by physicians [45].  
 
Research that solicits the experiences of patients with diabetes at higher risk for 
vision loss, namely racial and ethnic minorities and patients with low socioeconomic 
status, is necessary to understand how this unique population engages with diabetic eye 
care. Understanding the factors that influence receipt of eye care by high-risk patients 
with diabetes is essential for the design of effective interventions that increase screening 
utilization and decrease the burden of DR. In this study, we present the findings from 
individual qualitative interviews with high-risk diabetic patients from a federally 
qualified community health center about their use of DR screening, and propose a 
theoretical framework to characterize the factors that influence receipt of diabetic eye 
care in this population.   




I. Qualitative Methods and Their Utility  
Qualitative research is research that attempts to answer why or how a 
phenomena occurs using non-numerical data. It typically uses inductive rather than 
deductive reasoning and seeks to generate rather than test hypotheses [46]. Qualitative  
methods may be useful in describing a range of phenomena, as Curry et al describes:   
“Although quantitative methods have historically been the primary approach in 
health sciences research, many contemporary phenomena in health and health 
care are difficult, if not impossible, to measure using quantitative approaches 
alone. Examples include complex and dynamic social processes; beliefs, values, 
and motivations that underlie individual health behaviors; and social, political, 
economic, and organizational contexts relevant to health…The goal is to produce 
depth of understanding, and perhaps generate hypotheses regarding a 
phenomenon, its precursors, and its consequences [46].” 
 
Qualitative methods offer a way to explore the diverse experiences of patients, 
particularly from at-risk communities [14–16][46]. In qualitative research, data is 
typically collected through observational or descriptive methods, such as one-on-one 
interviews or focus groups, using purposeful sampling of individuals with direct 
experience or knowledge of the topic under study. Data is analyzed in an iterative 
manner in which data is collected, coded, and interpreted. The products of analysis in 
qualitative data often include recurrent themes, hypotheses, or conceptual models [46].  
 
In this study we sought to understand the factors influencing DR screening 
utilization by patients from racial/ethnic minority groups and low socioeconomic status. 
The complexity of this phenomena makes qualitative methods an ideal method to gain 
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understanding about the personal choices and factors that influence individual patient’s 
decision-making. 
 
In this study, the data was gathered and analyzed in accordance with the 
principles of grounded theory, a systematic methodology in which theories are 
developed through inductive reasoning [47]. As qualitative data is reviewed, repeated 
concepts are tagged with “codes,” and refined as more data is collected and codes are 
re-reviewed. Then, codes can be grouped within concepts and larger categories that may 
become the basis for a new theory. This allows the researcher to “develop a theoretical 
account of the general features of a topic while simultaneously grounding the account in 
empirical observations or data [48].” 
 
II. Setting  
The institutional review board of Yale University approved the study protocol 
and exempted it from continued oversight. Discussion with leaders of local community 
health organizations through the Yale Center for Research and Engagement informed 
the study design. The mission of the center is to “facilitate the collaboration of 
community organizations with trainees to design and implement research projects on 
topics identified as priorities by the New Haven community [49].”  
 
 Semi-structured, qualitative interviews were conducted with patients with 
diabetes at the Cornell Scott Hill Health Clinic, a federally-qualified community health 
center (FQHC) in New Haven, CT, and its satellite clinics in New Haven and nearby 
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Ansonia, CT. Additional interviews were conducted at the Yale Primary Care Clinic in 
New Haven, CT. The FQHC serves a patient population that is 69% Black or Latino 
and 64% of patients have income below the poverty line [50]. The Yale Primary Care 
Clinic serves a similar patient population. The interview settings included primary care 
clinics, a diabetes/wellness education center, and an on-site eye clinic.  
 
III. Participants  
A convenience sample of English-speaking patients with diabetes was recruited 
by approaching patients before or after their appointments. Author E. Fairless recruited 
26 of the 30 participants, and A. King, also a medical student, recruited the remaining 6. 
All participants gave written informed consent and consent to be audio-recorded. No 
compensation was given to the first 24 participants, the 6 final participants received $20 
gift cards for their time. Only patients with a diagnosis of diabetes for at least one year 
were included. Self-reported participant demographic information was collected, 
including age, gender, race/ethnicity, insurance status, time since diagnosis with 
diabetes, time since last eye exam, and frequency of eye exams.  
 
IV. Participant Interviews 
Semi-structured qualitative interviews were conducted in English with 
participants by in a one-on-one setting. Author E. Fairless conducted 24 out of 30 
interviews, and A. King conducted an additional 6 interviews. Based on the principles 
of grounded theory, the purpose of these interviews was to generate hypotheses rather 
than to test a predetermined hypothesis [46,47,51]. Participants were asked open-ended 
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questions about their experiences with eye exams, what factors influenced their decision 
to pursue or not to pursue an eye exam, and any barriers they might have faced to 
accessing eye care. Author E. Fairless developed the interview guide that was used to 
direct questioning (Table 1).  
 
Interview Guide 
When was the last time you had an eye exam? How often do you get eye 
exams? 
Can you tell me about your experience the last time you had an eye exam? 
What made you decide to get an eye exam? What motivated you to go? 
At the time that you were diagnosed with diabetes, what, if anything, were 
you told about eye care? 
Have you ever been told by a healthcare provider that diabetes can affect 
your eyes? 
How did you learn that diabetes can affect your eyes? Has anything ever prevented you from having an eye exam? Have you ever 
cancelled or not shown up to an eye exam appointment? If so, why? 
 
Table 1. Interview guide.  
 
 
Follow-up questions were used to encourage participants to elaborate as necessary. The 
interview guide was periodically re-evaluated and rephrased by the author using a 
reflection checklist as necessary to ensure clarity and internal validity [51].  
 
V. Data Analysis  
The interviews were recorded using a H4next Handy Recorder (ZOOM 
corporation.), transcribed verbatim with Trint online transcription service (Trint Ltd.), 
and analyzed with NVivo software, version 11 (QSR International.) The author E. 
Fairless transcribed the 24 interviews she conducted, and A. King transcribed the 6 
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interviews she conducted. The transcripts were analyzed according to the concepts of 
grounded theory [47]: the transcripts were reviewed line by line and codes were created 
to define concepts inductively from the data. Coded text was reviewed to identify 
overarching themes and codes were refined as appropriate until a final comprehensive 
coding framework was reached. All interviews were reviewed and coded by author E. 
Fairless. Dr. K. Nwanyanwu reviewed the transcripts and coding.  
 
This coding framework became the basis of a theoretical model of factors affecting 
screening utilization. Author E. Fairless and Dr. K. Nwanyanwu developed the 
theoretical model. The broader themes of the coding framework were organized in a 
socio-ecological model, which situates health behaviors in the context of individual 
(e.g. attitudes, behaviors), social (e.g. social networks, social support), and structural 
(e.g. access to care) factors [52,53].  
 




I. Participant Demographics 
A total of 30 people participated in the study. The median age of participants was 
57.3 (range 35 –73). Fifteen participants identified as female and 15 as male. 
Participants identified as black (16), white (5), Hispanic (5), Asian (1), and 
other/declined to answer (3). Twenty-eight participants had health insurance. Twenty-
four had received an eye exam within in the past year, but one-third (10) of participants 
reported they did not receive eye exam yearly. Half of the participants had had diabetes 
for over 10 years. The demographic information is summarized in Table 2. 
 
Demographic Information N = 30 
Age, median (range) 57.3 (35-73) 
Gender, No. (%)  
  Female 15 (50) 
  Male 15 (50) 
Race/ethnicity, No. (%)  
  Black 16 (53) 
  White 5 (16.6) 
  Hispanic/Latino 5 (16.6) 
  Asian 1 (3.3) 
 
 
  Other/declined to answer 3 (10) 
 
Insurance Status, No. (%)  
  Insured 28 (93) 
  Uninsured 2 (7) 
Most Recent Eye Exam, No. (%)  
  Within previous 12 Months 24 (80) 
  Not within previous 12 months 6 (20) 
Eye Exam frequency, No. (%)  
  Annually or more frequently 20 (66) 
  Less frequently than annually 10 (33) 
Duration of diabetes, No. (%)  
1 to 5 years 12 (40) 
6 to 9 years 3 (10) 
10 years or longer 15 (50) 
Table 2. Participant demographic information.  
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II. Interview Comments 
415 interview comments were coded at 22 nodes under 7 broader themes. These 
themes were further classified into either individual factors or institutional and 
structural factors based on a socio-ecological model. Individual factors included the 
themes of vision status, competing concerns, and emotional context. Institutional and 
structural factors included the themes of resource availability, in-clinic experience, cues 
to action [54,55], and knowledge-creating experiences. This coding framework became 
our theoretical model of the factors affecting utilization of eye examinations in our 
patient population (Figure 1). 





Figure 1: Theoretical framework of factors affecting utilization of eye exams in patients 
with diabetes, and representative quotes from participants.  
 
 
Individual factors. Individual factors included vision status, competing 
concerns, and emotional context. Individual factors encompassed factors that were 
either specific to a patient, such as attitude and behaviors, health issues, or were factors 
closely relating to their daily lives.  
 
Vision status: Many participants indicated that changes in their vision or a need 
for updated corrective lenses was the primary factor that prompted them to seek an eye 
examination. In the absence of any visual symptoms, some participants saw no reason 
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to obtain an eye exam. One participant with diabetic retinopathy recalled not seeking an 
eye exam until his vision was affected by a retinal hemorrhage: “[The doctors] started 
saying ‘You gotta see an eye doctor.’…[I] blew off the first appointment, and then I was 
half-blind, so I saw the doctor properly.” Another participant stated ‘It wasn’t until I 
myself noticed a difference in my own eyesight that made want to [get an exam.]” Many 
participants stated that updating their glasses each year was an independent motivating 
factor to get exams regardless of their need for DR screening.  One participant with gout 
recalled: “I was struggling to get here [to the eye clinic]. I wasn't gonna come. I was 
going to call because of my foot, because I can't put pressure on my foot… I made it 
here, I struggled. Again, because I want some new glasses.” 
 
Competing concerns: Participants expressed that competing concerns such as 
other health problems, childcare responsibilities, struggles with addiction, and 
employment scheduling influenced their ability to get regular eye exams. One 
participant recalled that her previous job schedule kept her from making health 
appointments: “I canceled a few appointments over the last three months because I had 
a new job. So now I'm going to work on getting all those appointments rescheduled and 
done because I'm not working now.”  
 
Emotional context: Some participants expressed fear or hesitation about 
receiving eye exams because they were concerned that they would receive bad news 
about their health or because they wanted to avoid painful procedures. One participant 
stated: “I didn't think I needed [an eye exam]. And a lot of times when I go to the doctor 
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all of the sudden I need stuff. And I didn't want that to happen, I wanted to think that my 
eyes were going to be OK.” In contrast, others indicated that a desire to be informed 
about their health motivated them to seek exams. Some participants mentioned having a 
major health event, such as a hospitalization, that was a “wake up call” that motivated 
them to be proactive about accessing healthcare.  
 
Institutional and structural factors. Institutional and structural factors that 
influenced receipt of eye care included resource availability, in-clinic experience, cues 
to action, and knowledge-creating experiences.  Institutional and structural factors were 
defined as factors relating to the patient-provider relationship, the healthcare system, or 
larger social structures.  
 
Resource availability: Insurance status and the cost of an eye exam were 
important factors for participants, particularly among those that had not received an eye 
exam in the last year. One participant describes not returning to the eye clinic because 
of lack of funds: “I didn't have the money to pay for the amount of money [the eye 
clinic] said that I had to pay… I know that [an exam] was important. But I – as a single 
parent with three kids – I mean, seeing was not a priority at that time.”  Another patient 
reported that despite ongoing eye symptoms, he did not get an exam because “it was a 
financial thing… I didn’t have the money for it.” Some participants reported being 
uninsured as a barrier to receiving eye care One participant reported that “I was doing 
like a yearly exam…but I haven’t got one since I haven’t had any insurance maybe 5 
years.” She further elaborated that despite prompting by her doctor to get an eye exam, 
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she could not find an eye clinic that would see her without insurance coverage. She 
reported her income put her a coverage gap where she made too much to qualify for 
state Medicaid, but not enough to afford her employer’s health insurance. Several 
participants commented that they received eye exams only every two years, as they 
believed that annual exams were not covered by their insurance (however, medically 
necessary eye exams for patients with diabetes are typically covered annually by most 
insurance plans.)  
 
Access to transportation to the eye clinic was another important factor, though 
most participants reported that they had no issues with finding adequate transportation. 
Additionally, some participants reported that experiencing homelessness or being 
incarcerated prevented them from seeking eye exams. One participant described not 
having access to eye care while incarcerated: “I was in prison, so they didn’t- they don’t 
do all that [eye care]. So when I came home I got everything done.”  
 
In-clinic experience: Participants reported that communication with their 
healthcare providers influenced their use of eye care either positively or negatively. One 
patient with a positive experience said, “The diabetes has not affected me so far from 
what [the doctor] tells me when she sees me in here [at the eye clinic.]...I think the 
process works. They are on top of it every year when they go in they are doing the full 
work up on me and letting me know that nothing's happening so far.” Another 
participant spoke about conflicting information from her providers:  
“I'm still having these blurred visions as of today, and- but they're saying that my 
eye vision is OK… I don't really know what to think of it because this [doctor] 
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saying that and this one is saying that, but I still have the blurry vision from time 
to time…what can I do about it? And this one's saying it's OK, this one's saying I 
have a trace of cataract but don't worry about it.” 
 
Other participants described instances of clear miscommunication: one participant who 
needed surgery on his retina mistakenly believed that the doctors would remove his eye 
to perform the surgery. Participants reported that feeling respected by their eye doctor 
and having good interactions with clinic staff were also factors that influenced their 
experience with eye care.  
 
Cues to action: Participants reported that being prompted by a primary care 
provider to receive an eye examination played a large role in their decision to seek an 
eye exam. One participant said: “If the doctor would suggest me have an eye exam, 
regardless of whether I had diabetes or not I would have followed out the instructions. 
If I was on my own I don't think I would have.” This is exemplified by the experience of 
another participant who reported being told about the importance of an eye exam and 
appropriately referred:  
“[My doctors] told me you have to get [an eye exam] done because we want to 
see if there's any damage done by you having diabetes and high blood pressures, 
so they can both damage your eyesight. And that's why they referred me from 
here. They did the appointment and everything, and then all I had was a phone 
call and come in.” 
 
In contrast, another participant felt that eye care was not emphasized by his 
primary care provider, which delayed his seeking an eye exam:  
“I should have been scared into going [to the eye doctor] a little bit, or at least, 
you know, given some kind of explanation as to what [diabetic retinopathy] was. 
It seemed to be at the bottom of the list. I have a lot of side effects from diabetes 
like neuropathy and, you know. But my eyes for some reason seemed to be at the 
bottom of the list of the importance layer when I talked to doctors.” 
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Participants also reported that following an annual exam schedule and getting 
appointment reminders were useful prompts to seek eye exams.  
 
Knowledge-creating experiences: Several participants reported experiences 
that informed them about diabetes’ effects on the eye and motivated them to obtain eye 
examinations. Some participants learned about diabetic eye disease from their provider, 
while others learned from family and friends with diabetes. Some participants reported 
knowing people who had become blind from diabetic eye disease. For one man, this 
was a powerful motivator to get exams: “One of my sisters lost her eyes [because of 
diabetes]…I watched what my sister went through… when I think of her living in 
darkness for so long…I don’t want to do that if I don’t have to.” 
 
In contrast, some participants appeared to be unaware or misinformed about 
diabetic retinopathy: one participant believed that cataract surgery protected him from 
diabetic eye disease: “The diabetes… won't affect me because I've got it - I got lenses in 
my eyes. So…it don't really affect my vision like it do some people…They said I could 
go get an eye exam, but what am I getting the eye exam for? I already see long 
distance….” Some participants stated that they had never been told by their doctor that 
diabetes could affect their eyes or that they needed a diabetic eye examination. One 
participant states: “I don't think as far as being diagnosed with diabetes…I don't recall 
no one telling me [about eye exams], and I'm being completely honest.” 
 
  
   
 27 
Discussion 
Diabetes is a burdensome disease that places patients, especially racial/ethnic 
minorities and people with low socio-economic status, at risk of developing diabetic 
retinopathy and vision loss [26,36,39–41]. Many patients at high risk of developing DR 
are not receiving the annual screening examinations necessary to identify DR and 
intervene before preventable vision loss occurs [18,22,26]. We have proposed a 
theoretical framework of factors that influence receipt of DR screening based on 
qualitative interviews with high-risk patients with diabetes. These factors are complex 
and the results of this qualitative study add depth and detail to our understanding. The 
participants in this study spoke about the emotional context behind their disease, their 
satisfaction or frustration with their providers’ communication, and their experiences 
balancing the demands of their lives with their health issues and available resources.  
 
The results of our interviews indicate a gap in many patients’ understanding of 
DR and the utility of preventative eye care. Although DR is asymptomatic in its early 
stages, many participants did not seek eye care unless they noticed changes in their vision 
or they did not perceive a need for annual eye exams if they felt their vision was good. 
Many participants stated that their need for glasses or contacts was a main motivating 
factor to pursue a yearly eye exam. It is unclear whether these participants would still be 
receiving eye exams to screen for DR if they did not already visit the eye doctor for 
corrective lenses. Participants exhibited a range of knowledge about DR, with some 
participants understanding that blindness can result from DR and others only expressing 
that they knew vision could be affected in some way.   
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 Our results reinforce the important role primary care providers play in educating 
patients about DR and prompting them to stick to annual examination schedules. Many 
participants identified their provider’s prompting as a leading reason they sought an eye 
exam, even if they did not fully understand the role of an eye exam in their diabetes care 
– though education by a provider about DR was demonstrably positive too. 
Unfortunately, several participants reported never being told by their primary care 
provider about diabetes’ effects on the eye and the need for eye exams, or reported that 
they felt eye exams were not emphasized by their provider. Patients with diabetes often 
have complex medical needs, other comorbidities, and often other specialists they must 
see on an ongoing basis, such as podiatry and dentistry. It is therefore not surprising that 
primary care providers often have little time during an appointment to discuss eye care. 
The chronic care model is a framework that has been shown to improve the quality of 
diabetes care [56]. It includes, among many things, an expanded role for health care 
teams and electronic health record tools that can help coordinate delivery of care, both of 
which may be useful to primary care providers taking care of the complex needs of 
patients with diabetes.  
 
Our results also show that insurance continues to be an important factor 
influencing patients’ receipt of eye care, with lack of insurance being a frequently cited 
barrier among patients who had not received an eye exam in the past year. In addition,  
the overlapping benefits of vision insurance and medical insurance are a source of 
confusion for some patients that may negatively impact screening adherence [55]. 
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Physicians and other healthcare professionals must continue to advocate for policies that 
expand insurance coverage.  
 
Many of the factors influencing the receipt of DR screening identified by this 
study, such as insurance status, communication with physicians, burden of systemic 
disease, absence of visual symptoms, and no perceived need for examination,  align with 
barriers identified by previous literature about receipt of eye care more generally 
[18,28,44]. There are several limitations to our study. Though this study drew participants 
from a population that is at higher risk for screening non-adherence, patients who had 
indeed received an eye exam within the past year were over-represented in this study. 
Nonetheless, these participants provided valuable insights on factors that facilitated DR 
screening, and many commented on periods in the past when they were unable to receive 
eye care. Patients who have not been screened may be less likely to seek primary care as 
well, and were therefore difficult to capture in this study design. Finally, by nature of 
being a qualitative study, our data does not allow us to quantitative comparisons about 
any of the factors affecting screening that were identified.  
 
New, innovative approaches are necessary to increase awareness about DR, 
expand access to screening, and increase screening utilization. Telemedicine provides one 
such approach, in which digital retinal photographs are taken and sent to reading centers 
for interpretation. Telemedicine can provide high diagnostic accuracy, increase rates of 
DR screening, and can be an important tool in settings that serve minority patient 
populations [58–61]. In addition, electronic health records are a tool that can generate 
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screening reminders and improve communication and coordination between primary care 
providers, eye care providers, and patients to facilitate screening [62]. Finally, federally 
qualified community health centers (FQHCs) are well-positioned to address the eye care 
disparities in high risk patient populations, but further integration of eye care services is 
necessary [63,64]. The FQHC in this study had an on-site comprehensive eye clinic, 
making it among the only 29% of FQHCs that provide on-site dilated eye examinations 
for patients with diabetes [63,65].  
 
Further research is essential to furthering our understanding of underutilization of 
care, barriers to care, and factors that facilitate access. The findings reported here may 
provide the basis for interventions to increase screening utilization in high-risk 
populations. Improving the utilization of DR screening by high risk populations is a 
critical imperative given the disproportionate burden of DR and preventable diabetes-
related blindness faced by these populations.  
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